Skip to content
About Us
Alzheimer’s Disease
Current Treatments
Our approach: ALPHA-1062
Clinical Trial Results
ALS
Our approach: ALPHA-602
Preclinical Results
Our Patents
Our Pipeline
News
Contact Us
X
News
June 8, 2020
ACI Attends the 2020 BIO Digital Partnering Conference
May 13, 2020
Business TV: Alzheimer’s Treatment with Minimal Side Effects
May 12, 2020
ACI Announces Granted EU Patents and Orphan Drug Designation for its Progranulin Platform
April 30, 2020
Alpha Cognition Inc. Receives FDA/PMDA Regulatory Guidance for Alpha-1062 Alzheimer’s Therapy
April 21, 2020
Linical and Alpha Cognition Announce Strategic Partnership
April 9, 2020
Alpha Cognition Inc. Announces its Name Change
